CI Stock Recent News
CI LATEST HEADLINES
Cigna's strong growth, favorable valuation, and shareholder policies justify a "buy" rating, outperforming the S&P500 with a 37% return since May 2023. The integration of insurance with pharmacy benefit management, particularly through Evernorth, enhances cost control and customer retention, driving significant revenue growth. Despite rising medical costs and public dissatisfaction with insurers, Cigna's strategic focus on commercial health plans and PBMs mitigates risks and supports future growth.
NEW YORK--(BUSINESS WIRE)--Cigna Healthcare has selected Baron Capital, a premier asset management firm focused exclusively on delivering growth equity investment solutions to institutions, financial advisors, and individual investors, as a recipient of their 2024 gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. Baron Capital's Health and Wellness Program continues to evol.
BLOOMFIELD, Conn. , April 4, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will release its first quarter 2025 financial results on Friday, May 2, 2025, and will host a conference call the same day.
Policy update increases access for millions covered by Evernorth Health Services Policy update increases access for millions covered by Evernorth Health Services
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna achieved 8%-9% YoY EPS growth in 2023-2024, demonstrating strong cost discipline and effective management. The sale of Cigna's Medicare unit and focus on lower-cost biosimilars and streamlined care accessibility are key strategic moves for future growth.
Washington, D.C., March 26, 2025 (GLOBE NEWSWIRE) -- Cigna Healthcare has selected MissionSquare, an organization that advocates for retirement security and financial well-being, as a recipient of their 2024 Gold Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program.
AIN, EFX and CI have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2025.
BLOOMFIELD, Conn. , March 19, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC).
Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's chief operating officer, and promoting his deputy Ann Dennison to the top finance role.
Brian Evanko named President and Chief Operating Officer, The Cigna Group Ann Dennison named Executive Vice President and Chief Financial Officer, The Cigna Group Nicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise Marketing Eric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna Group Reaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn. , March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE: CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.